Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1429141

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1429141

North America Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Mycoplasma Testing Market would witness market growth of 10.8% CAGR during the forecast period (2023-2030).

Mycoplasma testing refers to detecting and identifying mycoplasma bacteria in biological samples, such as cell cultures and clinical samples. Mycoplasma is a group of small bacteria that lack a cell wall and survive in various environments, including laboratory cell cultures. They can contaminate cell cultures, leading to changes in the behaviour and characteristics of the cells and affecting the experimental research results. Therefore, this testing is important in cell culture research and manufacturing biological products to ensure the purity of the cultures and prevent contamination.

Mycoplasma contamination in the complex processes of biopharmaceutical production can result in substantial financial losses, production delays, and compromised product quality. The imperative drives the adoption of this testing in this sector to identify and mitigate the risk of contamination early in the production chain. Robust testing protocols are integral to ensuring the integrity of biopharmaceutical products and safeguarding investments in research and development.

Biomanufacturing facilities in Mexico, producing vaccines, monoclonal antibodies, and other biopharmaceuticals, implement this testing as a critical quality control measure. The development and manufacturing of cell-based therapies in Mexico, including regenerative medicine and personalized cell therapies, drive the need for this testing. Facilities involved in cell line banking in Mexico, where cells are stored and distributed for research and production purposes, implement this testing to maintain the quality of stored cell lines. This testing plays a role in preventive healthcare measures in Mexico, particularly in diagnostic laboratories where cell cultures are used for various diagnostic purposes. Advances in cell and gene therapies in Mexico contribute to the growing importance of this testing. Therefore, the factors mentioned above will drive the regional market growth.

The US market dominated the North America Mycoplasma Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $541.8 million by 2030. The Canada market is experiencing a CAGR of 13.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 12.3% during (2023 - 2030).

Based on Product & Service, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into PCR, ELISA, Microbial Culture Techniques, and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • InvivoGen SAS
  • Asahi Kasei Corporation
  • F. Hoffmann-La Roche Ltd.
  • Norgen Biotek Corp.
  • PromoCell GmbH

North America Mycoplasma Testing Market Report Segmentation

By Product & Service

  • Kits & Reagents
  • Instruments
  • Services

By Technology

  • PCR
  • ELISA
  • Microbial Culture Techniques
  • Enzymatic Methods

By Application

  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Mycoplasma Testing Market, by Product & Service
    • 1.4.2 North America Mycoplasma Testing Market, by Technology
    • 1.4.3 North America Mycoplasma Testing Market, by Application
    • 1.4.4 North America Mycoplasma Testing Market, by End User
    • 1.4.5 North America Mycoplasma Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. North America Mycoplasma Testing Market by Product & Service

  • 4.1 North America Kits & Reagents Market by Country
  • 4.2 North America Instruments Market by Country
  • 4.3 North America Services Market by Country

Chapter 5. North America Mycoplasma Testing Market by Technology

  • 5.1 North America PCR Market by Country
  • 5.2 North America ELISA Market by Country
  • 5.3 North America Microbial Culture Techniques Market by Country
  • 5.4 North America Enzymatic Methods Market by Country

Chapter 6. North America Mycoplasma Testing Market by Application

  • 6.1 North America Cell Line Testing Market by Country
  • 6.2 North America Virus Testing Market by Country
  • 6.3 North America End of Production Cells Testing Market by Country
  • 6.4 North America Others Market by Country

Chapter 7. North America Mycoplasma Testing Market by End User

  • 7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
  • 7.2 North America Contract Research Organizations Market by Country
  • 7.3 North America Academic Research Institutes Market by Country
  • 7.4 North America Cell Banks Market by Country
  • 7.5 North America Others Market by Country

Chapter 8. North America Mycoplasma Testing Market by Country

  • 8.1 US Mycoplasma Testing Market
    • 8.1.1 US Mycoplasma Testing Market by Product & Service
    • 8.1.2 US Mycoplasma Testing Market by Technology
    • 8.1.3 US Mycoplasma Testing Market by Application
    • 8.1.4 US Mycoplasma Testing Market by End User
  • 8.2 Canada Mycoplasma Testing Market
    • 8.2.1 Canada Mycoplasma Testing Market by Product & Service
    • 8.2.2 Canada Mycoplasma Testing Market by Technology
    • 8.2.3 Canada Mycoplasma Testing Market by Application
    • 8.2.4 Canada Mycoplasma Testing Market by End User
  • 8.3 Mexico Mycoplasma Testing Market
    • 8.3.1 Mexico Mycoplasma Testing Market by Product & Service
    • 8.3.2 Mexico Mycoplasma Testing Market by Technology
    • 8.3.3 Mexico Mycoplasma Testing Market by Application
    • 8.3.4 Mexico Mycoplasma Testing Market by End User
  • 8.4 Rest of North America Mycoplasma Testing Market
    • 8.4.1 Rest of North America Mycoplasma Testing Market by Product & Service
    • 8.4.2 Rest of North America Mycoplasma Testing Market by Technology
    • 8.4.3 Rest of North America Mycoplasma Testing Market by Application
    • 8.4.4 Rest of North America Mycoplasma Testing Market by End User

Chapter 9. Company Profiles

  • 9.1 Charles River Laboratories International, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
  • 9.2 Thermo Fisher Scientific, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 Eurofins Scientific SE
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional Analysis
    • 9.3.4 Recent strategies and developments:
      • 9.3.4.1 Product Launches and Product Expansions:
      • 9.3.4.2 Acquisition and Mergers:
    • 9.3.5 SWOT Analysis
  • 9.4 Lonza Group Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 SWOT Analysis
  • 9.5 Bio-Rad laboratories, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 SWOT Analysis
  • 9.6 InvivoGen SAS
    • 9.6.1 Company Overview
    • 9.6.2 SWOT Analysis
  • 9.7 Asahi Kasei Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 F. Hoffmann-La Roche Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Norgen Biotek Corp.
    • 9.9.1 Company Overview
  • 9.10. PromoCell GmbH
    • 9.10.1 Company Overview
    • 9.10.2 SWOT Analysis

LIST OF TABLES

  • TABLE 1 North America Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 2 North America Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 3 North America Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 4 North America Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 5 North America Kits & Reagents Market by Country, 2019 - 2022, USD Million
  • TABLE 6 North America Kits & Reagents Market by Country, 2023 - 2030, USD Million
  • TABLE 7 North America Instruments Market by Country, 2019 - 2022, USD Million
  • TABLE 8 North America Instruments Market by Country, 2023 - 2030, USD Million
  • TABLE 9 North America Services Market by Country, 2019 - 2022, USD Million
  • TABLE 10 North America Services Market by Country, 2023 - 2030, USD Million
  • TABLE 11 North America Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 12 North America Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 13 North America PCR Market by Country, 2019 - 2022, USD Million
  • TABLE 14 North America PCR Market by Country, 2023 - 2030, USD Million
  • TABLE 15 North America ELISA Market by Country, 2019 - 2022, USD Million
  • TABLE 16 North America ELISA Market by Country, 2023 - 2030, USD Million
  • TABLE 17 North America Microbial Culture Techniques Market by Country, 2019 - 2022, USD Million
  • TABLE 18 North America Microbial Culture Techniques Market by Country, 2023 - 2030, USD Million
  • TABLE 19 North America Enzymatic Methods Market by Country, 2019 - 2022, USD Million
  • TABLE 20 North America Enzymatic Methods Market by Country, 2023 - 2030, USD Million
  • TABLE 21 North America Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 22 North America Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 23 North America Cell Line Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 24 North America Cell Line Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 25 North America Virus Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 26 North America Virus Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 27 North America End of Production Cells Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 28 North America End of Production Cells Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 31 North America Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 32 North America Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 33 North America Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
  • TABLE 34 North America Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
  • TABLE 35 North America Contract Research Organizations Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Contract Research Organizations Market by Country, 2023 - 2030, USD Million
  • TABLE 37 North America Academic Research Institutes Market by Country, 2019 - 2022, USD Million
  • TABLE 38 North America Academic Research Institutes Market by Country, 2023 - 2030, USD Million
  • TABLE 39 North America Cell Banks Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Cell Banks Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Mycoplasma Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Mycoplasma Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 45 US Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 46 US Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 47 US Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 48 US Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 49 US Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 50 US Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 51 US Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 52 US Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 53 US Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 54 US Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 55 Canada Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 56 Canada Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 57 Canada Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 58 Canada Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 59 Canada Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 60 Canada Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 61 Canada Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 62 Canada Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 63 Canada Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 64 Canada Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 65 Mexico Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 66 Mexico Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 67 Mexico Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 68 Mexico Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 69 Mexico Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 70 Mexico Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 71 Mexico Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 72 Mexico Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 73 Mexico Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 74 Mexico Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 75 Rest of North America Mycoplasma Testing Market, 2019 - 2022, USD Million
  • TABLE 76 Rest of North America Mycoplasma Testing Market, 2023 - 2030, USD Million
  • TABLE 77 Rest of North America Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
  • TABLE 78 Rest of North America Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
  • TABLE 79 Rest of North America Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
  • TABLE 80 Rest of North America Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
  • TABLE 81 Rest of North America Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 82 Rest of North America Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 83 Rest of North America Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 84 Rest of North America Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 85 Key Information - Charles River Laboratories International, Inc.
  • TABLE 86 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 87 Key Information - Eurofins Scientific SE
  • TABLE 88 Key Information -Lonza Group Ltd.
  • TABLE 89 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 90 Key Information - InvivoGen SAS
  • TABLE 91 Key Information - Asahi Kasei Corporation
  • TABLE 92 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 93 Key Information - Norgen Biotek Corp.
  • TABLE 94 Key Information - PromoCell GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!